Authors: MENSINK H

Citation: H. Mensink, EVALUATION OF BENIGN PROSTATIC HYPERPLASIA TREATMENTS - HOW CAN WE IMPROVE THE OUTCOME MEASURES AND SUCCESS CRITERIA, European urology, 32, 1997, pp. 38-41

Authors: VANBASTEN J JONKER G VANDRIEL M SLEIJFER D VANDERWIEL H MENSINK H KOOPS HS HOEKSTRA H

Citation: J. Vanbasten et al., SEXUAL DYSFUNCTIONS AFTER TESTICULAR CANCER (TC), European journal of cancer, 31A, 1995, pp. 905-905

Authors: BOUFFIOUX C KURTH KH BONO A OOSTERLINCK W KRUGER CB DEPAUW M SYLVESTER R DENIS L NEWLING D HALL R BRESSEL M CASSELMAN J SMITH P ROBINSON M KEUPPENS F TOLLEY D JAKSE G BOLLACK C VERGISON B HOEKSTRA W DASILVA FC GROEN J RICHARDS B PAVONEMACALUSO M VANDERMEIJDEN A ZWARTENDIJK H JACOBI G VANCAUBERG R SCHRODER F HIRDES D LEISINGER H RIEDL H LUDWIG P ROOZENDAAL K MARECHAL L VANAUBEL O CONSIDINE J DEBRUYNE F CARREIRA F DEWALL D MENSINK H VIGGIANO G

Citation: C. Bouffioux et al., INTRAVESICAL ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - RESULTS OF 2 -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER RANDOMIZED TRIALS WITH MITOMYCIN-C AND DOXORUBICIN COMPARING EARLY VERSUS DELAYED INSTILLATIONS AND SHORT-TERM VERSUS LONG-TERM TREATMENT, The Journal of urology, 153(3), 1995, pp. 934-941